about
Antidepressants recruit new neurons to improve stress response regulationInnovative drugs to treat depression: did animal models fail to be predictive or did clinical trials fail to detect effects?Naloxone potentiates anxiolytic-like actions of diazepam, pentobarbital and meprobamate but not those of Ro19-8022 in the ratPharmacological alterations of anxious behaviour in mice depending on both strain and the behavioural situationChronic Treatment with the IDO1 Inhibitor 1-Methyl-D-Tryptophan Minimizes the Behavioural and Biochemical Abnormalities Induced by Unpredictable Chronic Mild Stress in Mice - Comparison with FluoxetineEmotional behaviour as the result of stochastic interactions. A process crucial for cognition.Anxiety from a phylogenetic perspective: is there a qualitative difference between human and animal anxiety?Neurogenesis-independent antidepressant-like effects on behavior and stress axis response of a dual orexin receptor antagonist in a rodent model of depression.Association between repeated unpredictable chronic mild stress (UCMS) procedures with a high fat diet: a model of fluoxetine resistance in miceOpen questions in current models of antidepressant action.A molecular signature of depression in the amygdala.Agonistic behavior and unpredictable chronic mild stress in mice.Effects of unpredictable chronic mild stress on anxiety and depression-like behavior in mice.Effects of the selective nonpeptide corticotropin-releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice.Dysregulation of the hypothalamus-pituitary-adrenal axis predicts some aspects of the behavioral response to chronic fluoxetine: association with hippocampal cell proliferation.The neurobiology of depression and antidepressant action.A rat model of distractibility: effects of drugs modifying dopaminergic, noradrenergic and GABAergic neurotransmission.Measuring normal and pathological anxiety-like behaviour in mice: a review.State and trait olfactory markers of major depressionThe genetic basis of the pharmacological effects of anxiolytics: a review based on rodent models.Genetic basis of anxiety-like behaviour: a critical review.The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review.Perceptive biases in major depressive episode.Prenatal exposure to methylphenidate affects the dopamine system and the reactivity to natural reward in adulthood in rats.Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression.Early life genetic, epigenetic and environmental factors shaping emotionality in rodents.Chronic mild stress and antidepressant treatment alter 5-HT1A receptor expression by modifying DNA methylation of a conserved Sp4 siteNeuropeptides in psychiatric diseases: an overview with a particular focus on depression and anxiety disorders.Large-scale estimates of cellular origins of mRNAs: enhancing the yield of transcriptome analyses.Involvement of vasopressin in affective disorders.Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversalOlfaction: a potential cognitive marker of psychiatric disorders.Mechanisms of antidepressant resistanceThe design of new antidepressants: can formal models help? A first attempt using a model of the hippocampal control over the HPA-axis based on a review from the literature.Novel insights into depression and antidepressants: a synergy between synaptogenesis and neurogenesis?Hippocampal neurogenesis: a biomarker for depression or antidepressant effects? Methodological considerations and perspectives for future research.Neurogenesis along the septo-temporal axis of the hippocampus: are depression and the action of antidepressants region-specific?Optogenetics to study the circuits of fear- and depression-like behaviors: a critical analysis.Resistance to antidepressant drugs: the case for a more predisposition-based and less hippocampocentric research paradigm.Depression: from psychopathology to pathophysiology.
P50
Q24634257-E25C9136-CF23-4E78-AD79-13AF62CF38D4Q26996411-91557990-25A6-40C2-8345-6B50DF853AA3Q28377141-EA21B7F4-5915-4103-B226-1D308C76BA20Q28471826-ED85FF09-5446-4FDC-81E3-E413FE81A57DQ28553299-4E9D22C7-F9EC-472A-B24A-2DF8E8A84DFBQ30332207-BF9E846C-AE9D-4D17-81F7-83B1DD26F690Q30502573-2C113B13-2D82-4E9B-8DE5-DBD9E34CAE8DQ30524245-3D1BB952-A31E-4DF9-8D5B-2B02485495B0Q33570573-23212E04-2E40-49F8-AB25-6A0527BF6B19Q33767182-70D5F57E-6B97-4F3C-8C44-63272B28E8D9Q33899136-F431762C-DD89-4464-B387-ACC017C070CEQ33973357-395EC1EA-5600-48B5-B668-C3A088E9D6B5Q33999993-D8C48625-23FA-4C51-8908-04837E492D65Q34203078-508181FF-FA29-4C44-925A-EB8FB46BFC48Q34265505-9E0304A0-1567-429B-A56D-1553A1A03C1EQ34319150-667CA3A4-F492-4B79-8ED6-94B75B60B2F4Q34420395-6814A42E-DADF-4168-B65C-5934908C7F61Q34420641-75CAFD03-ABEA-460D-ACDE-919BECFA84F4Q34442545-DAD1313E-FA06-4228-B38C-8C097D7CFBD1Q34462227-78C4AC84-0BF1-44EB-95AE-8E1714042585Q34517497-599D8CCB-C17D-4D62-980F-CA09F43F9034Q35071470-CB70C080-4360-426A-9A77-75435AA084ECQ35099458-3813FA61-E576-493B-8FA3-3C20AE1C0648Q35179006-B4003A0E-6067-4C74-9BB8-EB2A740B98E9Q36061657-8D3359E0-2034-4062-B9C5-79AE60530BDCQ36226571-F2970C9C-A62F-48E2-AA82-E0CE77EB2CCFQ36268893-24D112E2-4DA5-4E00-9CEB-DD2FAD9BCBF5Q36447243-2247BD37-4143-44C1-821C-3E9273EB202EQ36487654-E8D80E4B-F743-4320-B1BE-61A8A52ECCABQ37078542-4F08D796-F1F8-4EA5-AD9A-9C2C6253307FQ37159953-61D4D3D3-741F-4EFF-B41A-C4604124F4FFQ37191733-35B402C8-1F37-4AF4-987F-1E991D36BA14Q37334088-CACD53D8-C2D7-4258-9C79-1A2C41AD22F5Q37807251-0C3B4E0D-6050-4B1C-84AA-24AE856440B9Q38070086-C9AC1988-E82C-4963-88E6-04165334F9D0Q38099755-7AAD7165-25BB-4BD4-BDF8-61C07FA5555EQ38131239-DDAE60ED-992F-40A7-A0AE-622A9B97885AQ38204177-6F202644-DA4B-44FF-96F7-F6A967F3311EQ38235974-C4DE7475-FFEA-41E4-B78A-535AC34C1F08Q38248863-CF66A813-6FE7-4AC7-9FE7-345454465419
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0001-6095-5974
@en
name
Catherine Belzung
@ast
Catherine Belzung
@en
Catherine Belzung
@es
Catherine Belzung
@nl
type
label
Catherine Belzung
@ast
Catherine Belzung
@en
Catherine Belzung
@es
Catherine Belzung
@nl
prefLabel
Catherine Belzung
@ast
Catherine Belzung
@en
Catherine Belzung
@es
Catherine Belzung
@nl
P214
P244
P106
P21
P214
P244
n2018187635
P31
P496
0000-0001-6095-5974
P735
P7859
lccn-n2018187635